Gross Margin StrengthSustained high gross margins point to durable manufacturing efficiency and pricing power in formulations. This structural advantage helps protect operating profits against volume swings and competitive pressure, supporting long-term cash generation and reinvestment capacity.

Balance Sheet HealthA healthy equity ratio and managed debt-to-equity indicate financial flexibility and lower solvency risk. This structural balance sheet strength supports funding of capex and working capital, enabling the company to execute growth initiatives and withstand sector cyclicality.

Improving Cash GenerationRecovering free cash flow and stronger operating cash flows signal improving conversion of profits to cash. Durable cash generation enhances capacity to reduce debt, fund R&D or manufacturing, and sustain dividends or share repurchases over the medium term.

Bears Say

Recent Revenue DeclineA recent ~22% revenue contraction is a material structural headwind that can erode scale benefits, reduce operating leverage, and pressure margins. Unless reversed by new product wins or market share gains, sustained top-line weakness risks long-term profitability trends.

Earnings Volatility (EPS)Very large negative EPS growth indicates substantial earnings deterioration or one-off shocks. Persistent EPS volatility undermines reinvestment planning and investor confidence and may reflect margin compression, higher costs, or non-recurring charges that impair long-term earnings quality.

Net Profit Margin PressureVolatile and recently declining net margins suggest difficulties controlling SG&A, pricing pressure, or rising input costs. Sustained margin erosion reduces free cash flow potential and limits ability to invest in growth or absorb regulatory and pricing headwinds over the medium term.

Themis Medicare Limited News

Themis Medicare Announces Special Window for Share Transfer Requests

The latest announcement is out from Themis Medicare Limited ( ($IN:THEMISMED) ). Themis Medicare Limited has announced a...

4M ago

Themis Medicare Limited Announces 55th AGM

Themis Medicare Limited ( ($IN:THEMISMED) ) has issued an announcement. Themis Medicare Limited has announced the convening of...

6M ago

Themis Medicare Announces Key Leadership Appointments and Financial Updates

Themis Medicare Limited ( ($IN:THEMISMED) ) has provided an update. Themis Medicare Limited announced significant changes in its...

7M ago

Themis Medicare Strengthens Leadership with Key Appointments

Themis Medicare Limited ( ($IN:THEMISMED) ) has provided an update. Themis Medicare Limited announced the appointment of Ms....

7M ago

THEMISMED FAQ

What was Themis Medicare Limited’s price range in the past 12 months?

Themis Medicare Limited lowest stock price was ₹75.80 and its highest was ₹182.45 in the past 12 months.

What is Themis Medicare Limited’s market cap?

Themis Medicare Limited’s market cap is ₹8.44B.

When is Themis Medicare Limited’s upcoming earnings report date?

Themis Medicare Limited’s upcoming earnings report date is May 27, 2026 which is in 93 days.

How were Themis Medicare Limited’s earnings last quarter?

Themis Medicare Limited released its earnings results on Feb 13, 2026. The company reported ₹1.096 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.096.

Is Themis Medicare Limited overvalued?

According to Wall Street analysts Themis Medicare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Themis Medicare Limited pay dividends?

Themis Medicare Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.48%. See more information on Themis Medicare Limited dividends here

What is Themis Medicare Limited’s EPS estimate?

Themis Medicare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Themis Medicare Limited have?

Themis Medicare Limited has 92,100,120 shares outstanding.

What happened to Themis Medicare Limited’s price movement after its last earnings report?

Themis Medicare Limited reported an EPS of ₹1.096 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.41%.

Which hedge fund is a major shareholder of Themis Medicare Limited?

Currently, no hedge funds are holding shares in IN:THEMISMED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Themis Medicare Limited

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.